
- Stock: In Stock
- Brand: Square Pharmaceuticals
- Product ID: Deflazacort Systemic Corticosteroid (Glucocorticoid)
100% Secure Payment
bKash | Nagad | Cards via SSLCommerz | COD
Monthly Medicines Available | Free Delivery on Eligible Orders
| Generic Name | Deflazacort |
| Strength | 24 mg |
| Dosage Form | Tablet |
| Manufacturer | Square Pharmaceuticals PLC |
| Therapeutic Class | Corticosteroid (Anti-Inflammatory / Immunosuppressant) |
| Pack Size | Each box contains tablets in blister strips |
Overview
Deflacort 24 mg Tablet contains Deflazacort, an oxazoline derivative of prednisolone with corticosteroid activity, manufactured by Square Pharmaceuticals PLC. It has similar anti-inflammatory and immunosuppressive properties to other corticosteroids but with a more favourable metabolic profile (particularly reduced calcium loss and less effect on glucose metabolism). It is used for rheumatoid arthritis, asthma, allergic disorders, systemic lupus erythematosus (SLE), inflammatory bowel disease, and other conditions requiring corticosteroid therapy.
Dosage and Administration
Adults: dose varies by condition — typically 6–90 mg/day adjusted as needed, prescribed as a single morning dose or in divided doses. For maintenance, use the lowest effective dose. 24 mg tablets allow precise dose titration.
Interaction
May reduce efficacy of antidiabetic agents (hyperglycaemia). NSAIDs increase GI risk. Vaccines may have reduced immunogenicity. Enzyme inducers (rifampicin, phenytoin) reduce deflazacort efficacy. Increases risk of hypokalaemia with diuretics.
Contraindications
Contraindicated in systemic infections (unless adequate antimicrobial cover), known hypersensitivity to deflazacort, and live vaccines during immunosuppressive doses.
Side Effects
Short-term: insomnia, euphoria, increased appetite, and fluid retention. Long-term: osteoporosis, adrenal suppression, hyperglycaemia, Cushingoid features, growth retardation in children, cataracts, and increased infection susceptibility.
Pregnancy and Lactation
Use with caution during pregnancy; may cause adrenal suppression in the neonate. Use the lowest effective dose. Not recommended during breastfeeding at high doses.
Precautions and Warnings
Do not stop abruptly after prolonged use — taper dose gradually to prevent adrenal crisis. Take with food to reduce GI side effects. Monitor blood glucose, blood pressure, and bone density with long-term use.
Storage Conditions
Store below 30°C in a cool, dry place. Protect from moisture. Keep out of the reach of children.
Frequently Asked Questions
How does deflazacort differ from prednisolone?
Deflazacort is an oxazoline ester of prednisolone with equivalent anti-inflammatory activity but reportedly less calcium loss and milder effects on body weight and glucose metabolism, making it preferred in some patient groups.
Why must corticosteroids not be stopped suddenly?
Prolonged use suppresses the adrenal glands' ability to produce cortisol; abrupt withdrawal can cause acute adrenal insufficiency (Addisonian crisis) — doses must be tapered gradually.
This content is for informational purposes only and does not substitute professional medical advice. Please consult a registered physician before taking any medication.















